webinar on Aug. 24 will feature a discussion of approaches to address the need
for antibiotic development, including recommendations designed to advance
clinical trials for antibiotics to treat hospital-acquired and
ventilator-associated bacterial pneumonia. The recommendations, developed by
the Clinical Trials Transformation
appeared in a recent Clinical Infectious
Diseases supplement. Established by Duke University and
the Food and Drug Administration, CTTI includes member organizations working to
develop and drive the adoption of practices that will increase the quality and
efficiency of clinical trials.
information about the webinar, “Antibacterial Drug Development in a Time of
Great Need: Global Expert Panel,” scheduled for noon to 1 p.m. EDT, on Aug. 24,
visit CTTI’s website.
< Previous Article | Next Article >